Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide Effect on Brain Dopamine Levels at Food Cognition
NCT07732426Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of semaglutide in obesity and Food addiction (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change in Dopamine Binding Potential During the Look, Smell, and Drink Period at 8 weeks. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
obesityFood addiction
Beyond the preview
Go deeper on NCT07732426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07732426.